Daniel S. Budnitz, MD, MPH; Nadine Shehab, PharmD; Scott R. Kegler, PhD; Chesley L. Richards, MD, MPH
Potential Financial Conflicts of Interest: None disclosed.
Budnitz DS, Shehab N, Kegler SR, Richards CL. Is It Safe to Conclude that Beers Criteria Medications Led to Few Adverse Events?. Ann Intern Med. 2008;148:629. doi: 10.7326/0003-4819-148-8-200804150-00018
Download citation file:
Published: Ann Intern Med. 2008;148(8):629.
We thank Dr. Golden and colleagues for their response to our recent article. They brought up several interesting issues, but we believe the critical issue for patient safety is identified by Dr. Krishnamurthy in his online letter (1). The estimated 59 000 emergency department visits each year caused by adverse events from the use of insulin, warfarin, and digoxin are harms that should be addressed. We stand by our conclusions that performance measures and interventions targeting the use of warfarin, insulin, and digoxin could prevent more emergency department visits for adverse events than measures targeting the use of “potentially inappropriate” medications.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only